Panel: Growing Pains: What’s Holding Back the Next Wave of Biopharma Innovators?

Session details:

Breakthrough science is driving a new era of therapies—but for many growing biopharma companies, innovation alone isn’t enough. As organizations scale, they often encounter hidden friction: siloed systems, regulatory bottlenecks, supply chain blind spots, and limited visibility that can slow progress at the most critical moments.  

This session explores how emerging biopharma organizations can use technology as a catalyst to bridge the divide between lab success and market readiness. Repligen will share the unseen challenges that can derail even the most promising biopharma innovators—and explores how technology, when thoughtfully applied, can help eliminate barriers to growth.   

What you’ll gain from this session:

• ​A candid look at the operational challenges most likely to stall biopharma scale-up
• Strategic insights on building flexibility and compliance into your foundation from day one
• ​Examples of how emerging companies are using technology to accelerate timelines without sacrificing quality
• A forward-looking perspective on aligning innovation with infrastructure to fuel long-term success
• Strategies used to gain management approval—turning ERP from a cost center into a growth enabler
• Measurable successes after implementation, including accelerated timelines, improved supply chain oversight, and greater operational agility